Novacel Therapeutics Private Limited
Pharmaceutical trading company dealing in chemicals, drugs, and medical equipment since 2014.
2014 | Guntur, Andhra Pradesh (India) | Active
Novacel Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -26.51%
- Profit Growth -23.97%
- Ebitda -19.33%
- Net Worth 62.24%
- Total Assets -21.00%
About Novacel Therapeutics
Novacel Therapeutics Private Limited (NTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 September 2014 and has a history of Ten years and five months. Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrasekhararao Bollu and Dama Prasad serve as directors at the Company.
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33116AP2014PTC095396
- Company No.
095396
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2014
- Date of AGM
21 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Pharma
Who are the key members and board of directors at Novacel Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrasekhararao Bollu  | Director | 27-Sep-2014 | Current |
| Dama Prasad | Additional Director | 14-Apr-2021 | Current |
Financial Performance of Novacel Therapeutics.
Novacel Therapeutics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 26.51% decrease. The company also saw a substantial fall in profitability, with a 23.97% decrease in profit. The company's net worth Soared by an impressive increase of 62.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novacel Therapeutics?
In 2019, Novacel Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Originix Healthcare Private Limited
Dama Prasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novacel Therapeutics?
Unlock and access historical data on people associated with Novacel Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novacel Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novacel Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
